Dechra Pharmaceuticals plc (LSE: DPH), has reported another solid performance for the Financial Year ended 30 June 2019. There was an all-round performance of the group and the revenue for the year surged by 17.5% to £481.8 million from £407.1 million in the FY2018. The underlying operating profit growth was of 27.3% to £127.4 million from £99.2 million of the last year. Operating profit of the group improved by 13.5% to £39.0 million from £34.1 million in FY2018. On the operational front, all the acquisitions’ performance was better than expected during the year.
On 2nd September 2019, at the time of writing, GMT 08:03 AM, DPH shares were trading at GBX 3,080.00, up by 80.00 points or 2.67% against the previous day closing price.